BIOSYNTIA ApS: Financial statements 2016
CVR: 34892970
BIOSYNTIA ApS (CVR 34892970) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 619,242 and a net result of DKK -2,837,632 compared with DKK -1,682,434 the year before. That is a decrease of 46.5% compared with the year before. Equity amounted to DKK 8,028,272. The solvency ratio was 79.2%. The company had 8 employees in the financial year.
- Gross Profit
- 619,242 kr.
- Profit/Loss
- -2,837,632 kr.
- Equity
- 8,028,272 kr.
- Total Assets
- 10,131,539 kr.
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 619 t. | -2.8 mio. | 8 mio. | 8 |
| 2015 | - | 1.2 mio. | -1.7 mio. | 3.9 mio. | - |
| 2014 | - | 1.6 mio. | -4 t. | 48 t. | - |
| 2013 | - | 389 t. | -28 t. | 52 t. | - |
How creditworthy is BIOSYNTIA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
As of July 4, 2016, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of BIOSYNTIA ApS.
As of July 4, 2016, RSM PLUS P/S STATSAUTORISEREDE REVISORER has stepped down as auditor of BIOSYNTIA ApS.
BIOSYNTIA ApS has published its annual report for 2015. Gross profit came to DKK 1,157,909, and the net result was DKK -1,682,434.
About BIOSYNTIA ApS
BIOSYNTIA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Martin Plambech. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and Sofinnova Industrial Biotech I. The company has 25 employees. In 2025, the company reported a gross profit of DKK -14,222,601 and a net result of DKK -20,066,332 compared with DKK -18,909,140 the year before. Equity amounted to DKK 32,860,576.
